Anatibant 2HCl

CAS No. 209788-45-4

Anatibant 2HCl( —— )

Catalog No. M34158 CAS No. 209788-45-4

Anatibant 2HCl is a small molecule bradykinin B2 receptor antagonist for the treatment of neurological disorders and may be used in the study of brain injury.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 922 In Stock
10MG 1140 In Stock
25MG 1511 In Stock
50MG 1841 In Stock
100MG 2325 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Anatibant 2HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Anatibant 2HCl is a small molecule bradykinin B2 receptor antagonist for the treatment of neurological disorders and may be used in the study of brain injury.
  • Description
    Anatibant 2HCl is a small molecule bradykinin B2 receptor antagonist for the treatment of neurological disorders and may be used in the study of brain injury.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Bradykinin Receptor
  • Recptor
    Bradykinin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    209788-45-4
  • Formula Weight
    784.58
  • Molecular Formula
    C34H36Cl2N6O5S.2ClH
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClC(C(S(=O)(N1[C@@H](CCC1)C(NCCCNC(C2=CC=C(C=C2)C(N)=N)=O)=O)=O)=CC=C3Cl)=C3COC4=CC=CC5=C4N=C(C)C=C5C.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Bradykinin (acetate)

    Bradykinin (acetate) is an active peptide that is generated by the kallikrein-kinin system. It is a inflammatory mediator and also recognized as a neuromediator and regulator of several vascular and renal functions. Enzymatically produced from kallidin in the blood, it is a powerful vasodilator that causes smooth muscle contraction, and may mediate inflammation.

  • MK-0686

    MK-0686 is an orally available bradykinin B1 receptor antagonist with potential anti-inflammatory activity.

  • Sar-[D-Phe8]-des-Arg...

    Potent and selective bradykinin B1 receptor agonist (EC50 = 9.02 nM in rabbit aorta) that is resistant to aminopeptidase, kininase I and II (ACE) and neutral endopeptidase cleavage. Exhibits hypotensive and angiogenic activity in vivo.